Charles River Laboratories International (NYSE:CRL) Given New $190.00 Price Target at Robert W. Baird
Charles River Laboratories International (NYSE:CRL – Free Report) had its price target decreased by Robert W. Baird from $191.00 to $190.00 in a research report released on Friday, Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Several other research analysts have also commented on the company. Argus […]
More Stories
Datadog, Inc. (NASDAQ:DDOG) Receives $139.88 Average PT from Analysts
Shares of Datadog, Inc. (NASDAQ:DDOG – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the thirty...
Brokerages Set Hexcel Co. (NYSE:HXL) Target Price at $74.54
Shares of Hexcel Co. (NYSE:HXL – Get Free Report) have earned a consensus rating of “Hold” from the thirteen analysts...
Hargreaves Services Plc (HSP) to Distribute Dividend of GBX 18 on November 4th
Hargreaves Services Plc (LON:HSP – Get Free Report) announced a dividend on Tuesday, August 6th, Upcoming.Co.Uk reports. Shareholders of record...
Nordic American Tankers Limited (NAT) to Issue Quarterly Dividend of $0.12 on November 26th
Nordic American Tankers Limited (NYSE:NAT – Get Free Report) declared a quarterly dividend on Thursday, August 29th, Zacks reports. Stockholders...
Healthcare Realty Trust (NYSE:HR) Releases FY 2024 Earnings Guidance
Healthcare Realty Trust (NYSE:HR – Get Free Report) updated its FY 2024 earnings guidance on Saturday. The company provided EPS...
Garda Property Group (ASX:GDF) Increases Dividend to $0.02 Per Share
Garda Property Group (ASX:GDF – Get Free Report) announced a interim dividend on Friday, September 20th, MarketIndexAU reports. Stockholders of...